Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Non-Current Assets: 2020-2025

Historic Non-Current Assets for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to $39.5 million.

  • Caribou Biosciences' Non-Current Assets fell 63.07% to $39.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.5 million, marking a year-over-year decrease of 63.07%. This contributed to the annual value of $93.9 million for FY2024, which is 0.61% up from last year.
  • Latest data reveals that Caribou Biosciences reported Non-Current Assets of $39.5 million as of Q3 2025, which was up 39.02% from $28.4 million recorded in Q2 2025.
  • Over the past 5 years, Caribou Biosciences' Non-Current Assets peaked at $113.5 million during Q4 2022, and registered a low of $12.9 million during Q3 2021.
  • In the last 3 years, Caribou Biosciences' Non-Current Assets had a median value of $93.9 million in 2024 and averaged $83.5 million.
  • In the last 5 years, Caribou Biosciences' Non-Current Assets soared by 611.69% in 2022 and then slumped by 72.18% in 2025.
  • Over the past 5 years, Caribou Biosciences' Non-Current Assets (Quarterly) stood at $51.2 million in 2021, then spiked by 121.87% to $113.5 million in 2022, then declined by 17.75% to $93.4 million in 2023, then increased by 0.61% to $93.9 million in 2024, then plummeted by 63.07% to $39.5 million in 2025.
  • Its Non-Current Assets stands at $39.5 million for Q3 2025, versus $28.4 million for Q2 2025 and $56.3 million for Q1 2025.